Wickham Micro

Wickham Micro

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Wickham Micro is an established, revenue-generating contract research organization (CRO) providing essential microbiological testing services to pharmaceutical and medical device clients globally. Its core business involves quality control, sterility testing, biocompatibility assessments, and method validation, ensuring regulatory compliance for product releases. The company differentiates itself through deep sector expertise, expedited testing options, and a strong ethical commitment to public health. As part of Cormica, it benefits from group resources while serving as a trusted partner to leading brands.

DiagnosticsInfectious Disease

Technology Platform

Platform of microbiological and biocompatibility testing services, including Sterility Testing, Bacterial Endotoxin (LAL) Testing, Cytotoxicity, Bioburden, and Microbial Identification via MALDI-ToF mass spectrometry.

Opportunities

Growth is driven by increasing outsourcing in pharma/device sectors, stringent global regulations, and demand for expedited testing services.
Expansion into testing for advanced therapies (ATMPs) and leveraging parent company Cormica's network present additional avenues.

Risk Factors

Key risks include intense competition from global CROs, dependency on maintaining stringent GMP/GLP regulatory compliance, and potential sensitivity to reductions in client R&D or manufacturing spending.

Competitive Landscape

Wickham Micro competes in the contract testing market against large international CROs (e.g., Charles River, Eurofins) and smaller niche labs. It differentiates through deep specialization in microbiology, a 60-year reputation, expedited service options, and a client-centric culture focused on trust and reliability.